4: Statement of changes in beneficial ownership of securities-Officer Gurrola Sandra M
04:40
4: Statement of changes in beneficial ownership of securities-Director Cicala Peter
04:40
4: Statement of changes in beneficial ownership of securities-Director Bristol James Arthur
04:38
Eterna Therapeutics | 8-K: Current report
Mar 23 04:34
Eterna Therapeutics | 10-K/A: Annual report (Amendment)
Mar 18 19:34
Eterna Therapeutics | 10-K: Annual report
Mar 15 04:41
Eterna Therapeutics | 3: Initial statement of beneficial ownership of securities-Director Cicala Peter
Feb 17 06:33
Eterna Therapeutics | 8-K: Current report
Feb 16 20:31
Eterna Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-John D. Halpern(9.99%),Katherine H. Halpern(9.99%)
Jan 31 20:06
Eterna Therapeutics | 424B3: Prospectus
Jan 25 05:20
Eterna Therapeutics | EFFECT: Others
Jan 23 13:00
Eterna Therapeutics | 8-K: Current report
Jan 19 13:00
Eterna Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Nicholas Jason Singer(9.99%),Purchase Capital LLC(9.99%)
Jan 19 13:00
Eterna Therapeutics | CORRESP: CORRESP
Jan 19 11:40
Eterna Therapeutics | UPLOAD: Others
Jan 18 11:44
Eterna Therapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Jan 16 13:00
Eterna Therapeutics | S-3: Registration statement for specified transactions by certain issuers
Jan 12 13:00
Eterna Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Luther Sanjeev
Jan 3 13:00
Eterna Therapeutics | 3: Initial statement of beneficial ownership of securities-Officer Luther Sanjeev
Jan 3 13:00
Eterna Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Clarke Dorothy J
Jan 3 13:00
No Data
No Data